 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
Neptune Wellness Solutions researches, develops and commercializes proprietary bioactive ingredients and products with the goal of superior added-value and clinically proven health benefits. The Company extracts a range of bioactive ingredients such as novel proprietary omega-3 phospholipids from abundant yet underexploited marine biomass including Krill, a cold deep water zooplankton. Neptune’s first commercially available product is Neptune Krill Oil (NKO®), which represents marine based omega-3 phospholipids with potential in cardiovascular, cognitive and anti-inflammatory disorders. Neptune is pursuing market opportunities in the nutraceutical market including dietary supplements and functional foods. The Company is also pursuing opportunities in the pharmaceutical market through its pharmaceutical subsidiaries,Acasti and NeuroBioPharm (including medical food, over-the-counter and prescription drug applications). neptunecorp.com NOTE: Neptune trades on Toronto.. For Canadian & US quote, enter NEPT Acasti Pharma Inc. is 35% owned by Neptune.. For Canadian & US quote, enter ACST acastipharma.com | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2024 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |